Explore how a dual GLP-1 agonist may improve obesity-related liver disease, with Phase 2 trial data highlighting histologic benefits and future clinical…
Explore how a dual GLP-1 agonist may improve obesity-related liver disease, with Phase 2 trial data highlighting histologic…
DLBCL radiotherapy offers strong consolidation after R-CHOP, though experts outline specific limitations for advanced-stage patients in clinical reviews.
Psoriasis and metabolic syndrome often occur together due to IL-17 signaling. Learn how these conditions are linked and…
Rare sarcoma trials are being unified under the OCTOPUS master protocol to speed drug development for ultra‑rare cancers,…
A new cancer drug reduces disease progression risk by 68% compared to chemotherapy in CLL and SLL patients,…
Alzheimer’s drug coverage faces slow, restrictive insurance approvals, but advocacy is improving access to new treatments for agitation.
Medicaid costs rise with late-stage cancer, study links Medicaid claims to cancer stage and spending patterns, affecting healthcare…
Closing the women's health gap with a $20 billion federal investment in women's health research and care.
Medicare Advantage Star Ratings influence billions in bonus payments and health plan enrollment with social risk factors considered.
Adding high-dose vitamin d3 chemotherapy failed to improve progression-free survival for metastatic colorectal cancer patients in the SOLARIS…
